Cite

HARVARD Citation

    Sesques, P. et al. (n.d.). Commercial anti‐CD19 CAR T cell therapy for patients with relapsed/refractory aggressive B cell lymphoma in a European center. American journal of hematology. 95 (11), pp. 1324-1333. [Online]. 
  
Back to record